Screener
Calidi Biotherapeutics CLDI Q2 2025 earnings
Reported August 8, 2025 · Before market open
EPS-$1.99Miss by $0.07
EPS estimate-$1.92
Next report
Nov 17, 2026 (in 2 months)Versus estimates
Diluted EPS
Q2 2026-$2.94Q1 2026-$0.43Q4 2025-$0.57Beat by $0.99Q3 2025-$2.21Miss by $0.53
Q2 2025-$1.99Miss by $0.07
Q1 2025-$2.16Miss by $2.01FAQ
- When did Calidi Biotherapeutics report Q2 2025 earnings?
- Calidi Biotherapeutics (CLDI) reported Q2 2025 earnings on August 8, 2025 before market open.
- What were Calidi Biotherapeutics's Q2 2025 revenue and EPS?
- Calidi Biotherapeutics reported eps of $-1.99 for Q2 2025.
- Did Calidi Biotherapeutics beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-1.92 by $0.07.
- How did Calidi Biotherapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 88.2% from $-16.81.
- Where can I find Calidi Biotherapeutics's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001641172-25-022592) and the 10-Q periodic report (0001641172-25-022797) directly on SEC EDGAR. The filing index links above go to sec.gov.
